Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Clara Flumian"'
Autor:
Romain Amadieu, Camille Brehin, Adéla Chahine, Erick Grouteau, Damien Dubois, Caroline Munzer, Clara Flumian, Olivier Brissaud, Barbara Ros, Gael Jean, Camille Brotelande, Brendan Travert, Nadia Savy, Benoit Boeuf, Ghida Ghostine, Isabelle Popov, Pauline Duport, Richard Wolff, Laure Maurice, Stephane Dauger, Sophie Breinig
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Bacterial infections (BIs) are widespread in ICUs. The aims of this study were to assess compliance with antibiotic recommendations and factors associated with non-compliance. Methods We conducted an observational study in eight F
Externí odkaz:
https://doaj.org/article/652d3727fcd44aeeb6a3684ab8cdc99e
Publikováno v:
BMJ Medicine, Vol 2, Iss 1 (2023)
Objective To assess the quality of reporting of adverse events in clinical trials of covid-19 drugs based on the CONSORT (Consolidated Standards of Reporting Trials) harms extension and according to clinical trial design, and to examine reporting of
Externí odkaz:
https://doaj.org/article/5b597045a21f4390a11636c699bcba09
Publikováno v:
Frontiers in Behavioral Neuroscience, Vol 12 (2018)
To study visual learning in honey bees, we developed a virtual reality (VR) system in which the movements of a tethered bee walking stationary on a spherical treadmill update the visual panorama presented in front of it (closed-loop conditions), thus
Externí odkaz:
https://doaj.org/article/925a124150594404a277ce3a2a962064
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
As two phase three clinical trials indicated a disproportion in the number of thromboembolic events in the tixagevimab/cilgavimab group than in the placebo group, there has been a cardiovascular safety concern with the use of anti-SARS-CoV-2 monoclon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ea3ac074a8264af2fd12b1a809b51a
https://pubmed.ncbi.nlm.nih.gov/36464214
https://pubmed.ncbi.nlm.nih.gov/36464214
Publikováno v:
Journal of the Neurological Sciences. 448:120644
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c28f880ee91fb7ca4e6cba8ef087d0a
https://doi.org/10.1016/j.jns.2023.120644
https://doi.org/10.1016/j.jns.2023.120644
Autor:
Déborah Foltran, Clément Karsenty, François Montastruc, Clara Flumian, Pierre De Paoli, Sophie Gautier, Clément Delmas, Francesco Salvo, Milou-Daniel Drici
Publikováno v:
European Heart Journal. Quality of Care & Clinical Outcomes
European Heart Journal. Quality of Care and Clinical Outcomes
European Heart Journal. Quality of Care and Clinical Outcomes, 2021, ⟨10.1093/ehjqcco/qcab090⟩
European Heart Journal. Quality of Care and Clinical Outcomes
European Heart Journal. Quality of Care and Clinical Outcomes, 2021, ⟨10.1093/ehjqcco/qcab090⟩
Aims While some concerns about vaccination-related pericarditis and/or myocarditis have been raised, no published data are available on pericarditis and/or myocarditis with mRNA COVID-19 vaccines in the age group of adolescents, particularly 12–15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d23d08f81ca58a7404bb4ec7b7d12f5b
http://europepmc.org/articles/PMC8690190
http://europepmc.org/articles/PMC8690190